
- Volume 0 0
Maine Rx Monitoring Program Targets Suspicious Prescribing
Officials at Maine's Office of SubstanceAbuse have begun collectingdetailed prescription data from everypharmacy in the state as part of acrackdown on prescription drug abuseby patients. The information gatheredfrom the pharmacies will be compiledtwice a month and searched for evidenceof "doctor shopping" by drugusers who try to obtain multiple prescriptionsfrom different physicians.
The program, which will focus onscheduled drugs with abuse potential,is designed to flag multiple purchasesby the same person, too frequent refills,and other suspicious patterns.
Significantly, however, Mainedoes not plan to use the monitoringprogram for law enforcement purposes.When suspicious activity isidentified, prescribers will beencouraged to review the patient'sdrug needs, adjust prescribing practices,and refer the patient for substanceabuse counseling whenappropriate.
The goal of the program is "to createa tool that may improve communitycare and reduce addiction andoverdose by stressing preventionand treatment," state officials said.Law enforcement authorities willbe able to subpoena specific informationfor a case they are alreadyinvestigating, but they can not go ona "fishing expedition," a spokesmanfor the state said.
Articles in this issue
about 21 years ago
Fluoroquinolones: Focus on Safetyabout 21 years ago
Computer Retrains Kids to Eat Properlyabout 21 years ago
"Importation" of Prescription Drugsabout 21 years ago
Courts Wrestle with Overtime Pay for Pharmacistsabout 21 years ago
COMPOUNDING HOTLINEabout 21 years ago
Clinical Update on the Treatment of Constipation in Adultsabout 21 years ago
Texas Hospital Installs Omnicell Technologyabout 21 years ago
Happy Harry's Installs Robotic Dispensing Systemsabout 21 years ago
Medicare Recognizes Obesity as Illnessabout 21 years ago
Gastric Bypass Causes Drop in Appetite StimulationNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.